Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
CH-Bioforce Oy
OY
Active
Y-tunnus 2739534-8
Tekniikantie 4C-431, 02150
Espoo
Manufacture of other chemical products n.e.c.
·
NACE 2059
Est. 2016 · 10 years old
9 employees
Share
Finland
/
Companies
/
Manufacture of other chemical products n.e.c.
/
CH-Bioforce Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
EUR millions
0M
-1M
-1M
-2M
-2M
2021: 0M
0M
2021
2022: -1M
-1M
2022
2023: -1M (0% vs 2022)
-1M
0%
2023
2024: -1M (0% vs 2023)
-1M
0%
2024
2025: -2M (-100% vs 2024)
-2M
-100%
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
33
129
86
212
166
Staff expenses
−1 040
−821
−786
−804
−667
EBITDA
−1 667
−1 326
−679
−979
−440
Depreciation & amort.
−121
−150
−261
−408
−376
EBIT
−1 788
−1 476
−941
−1 387
−816
Net financials
−412
−299
−247
−288
−133
Profit before tax
−2 200
−1 775
−1 187
−1 675
−949
Tax
−0
−0
−0
−0
−0
Net profit
−2 200
−1 775
−1 187
−1 675
−949
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
2 066
2 495
596
547
928
Equity
−4 737
−4 237
−4 237
337
−1 375
Long-term debt
4 787
4 287
4 287
—
1 823
Short-term debt
3 041
546
546
210
480
Total debt
7 828
4 833
4 833
210
2 304
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
−229,3 %
This company
38,2 %
Market median
This company
Market median
700% below market
2021
2025
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2021
2025
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,02×
This company
1,12×
Market median
This company
Market median
98% below market
2021
2025
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-06-01 – 2025-05-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-06-01 – 2024-05-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-06-01 – 2023-05-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-06-01 – 2022-05-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-06-01 – 2021-05-31
View
PDF
More on CH-Bioforce Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
